These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 2432845
1. [Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole]. Fauchier JP, Cosnay P, Rouesnel P, Moquet B, Huguet R, Wajman A. Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1495-505. PubMed ID: 2432845 [Abstract] [Full Text] [Related]
3. [Treatment of chronic ventricular extrasystole by propafenone (600 mg/d) in 2 or 3 daily doses]. Lardoux H, Valère PE, Djiane P, Maarek-Charbit M. Ann Cardiol Angeiol (Paris); 1993 May; 42(5):281-8. PubMed ID: 7690219 [Abstract] [Full Text] [Related]
4. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone]. Geibel A, Zehender M, Hohnloser S, Landsrath C, Meinertz T, Just H. Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720 [Abstract] [Full Text] [Related]
5. [Comparison between amiodarone and disopyramide in the treatment of ventricular extrasystoles]. Gaudeau B, Badouraly A, Herpin D, Tournadre P, Boutaud P, Amiel A, Guillem JP, Demange J. Ann Cardiol Angeiol (Paris); 1986 Jan; 35(1):43-8. PubMed ID: 2421631 [Abstract] [Full Text] [Related]
10. A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.). Eur Heart J; 1992 Sep; 13(9):1251-8. PubMed ID: 1396837 [Abstract] [Full Text] [Related]
12. [The circadian profile of ventricular extrasystole]. Paisana JP, Gomes F, Cruz J, Bonhorst D, Lopes D, Schneider V, Bruges G, Gil C. Rev Port Cardiol; 1993 Jan; 12(1):7-8, 23-32. PubMed ID: 7686016 [Abstract] [Full Text] [Related]
13. [Comparative multicenter clinical study of flecainide and amiodarone in the treatment of ventricular arrhythmias associated with chronic Chagas cardiopathy]. Rosenbaum M, Posse R, Sgammini H, Núñez Burgos J, Chiale PA, Pastori JD, González Zuelgaray J, Brunetto JF, Califano JE. Arch Inst Cardiol Mex; 1987 Jan; 57(4):325-30. PubMed ID: 2445316 [Abstract] [Full Text] [Related]
14. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment. Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A. G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218 [Abstract] [Full Text] [Related]
16. [Propafenone and flecainide in the therapy of ventricular arrhythmias]. Paperini L, Davini A, Lattanzi F, Topi A, Reisenhofer B, Squarcini G, Paci A, Topi PL. Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814 [Abstract] [Full Text] [Related]
17. [Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms]. Mastropasqua F, Totaro P, Massari F, Pitzalis MV, Rizzon P. Cardiologia; 1998 Jun; 43(6):617-23. PubMed ID: 9675961 [Abstract] [Full Text] [Related]